Evidence map›Paper›PMID 34325680›Full record

ArticleBMC public health2021

Incidence and predictors of hospital readmission in children presenting with severe anaemia in Uganda and Malawi: a secondary analysis of TRACT trial data.

Roisin Connon, Elizabeth C George, Peter Olupot-Olupot, Sarah Kiguli, George Chagaluka, Florence Alaroker, Robert O Opoka, Ayub Mpoya, Kevin Walsh, Charles Engoru and 19 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Observational
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Observational
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 12 institutions in 5 countries.

Roisin ConnonMRC Clinical Trials Unit at University College London, 90 High Holborn, London, WC1V 6LJ, UK. r.connon@ucl.ac.uk.ORCID 0000-0002-4408-4336
Elizabeth C GeorgeMRC Clinical Trials Unit at University College London, 90 High Holborn, London, WC1V 6LJ, UK.
Peter Olupot-OlupotMbale Clinical Research Institute, Pallisa Road, PO Box 291, Mbale, Uganda.
Sarah KiguliDepartment of Paediatrics and Child Health, School of Medicine, Makerere University and Mulago Hospital, PO Box 7072, Kampala, Uganda.
George ChagalukaCollege of Medicine, and Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Florence AlarokerSoroti Regional Referral Hospital, PO Box 289, Soroti, Uganda.
Robert O OpokaDepartment of Paediatrics and Child Health, School of Medicine, Makerere University and Mulago Hospital, PO Box 7072, Kampala, Uganda.
Ayub MpoyaKEMRI-Wellcome Trust Research Programme, PO Box 230, Kilifi, Kenya.
Kevin WalshInstitute of Global Health and Innovation, Department of Medicine, Imperial College London, London, SW7 2AZ, UK.
Charles EngoruSoroti Regional Referral Hospital, PO Box 289, Soroti, Uganda.
Julius NteziyaremyeMbale Clinical Research Institute, Pallisa Road, PO Box 291, Mbale, Uganda.
Macpherson MallewaCollege of Medicine, and Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Neil KennedyCollege of Medicine, and Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Margaret NakuyaSoroti Regional Referral Hospital, PO Box 289, Soroti, Uganda.
Cate NamayanjaMbale Clinical Research Institute, Pallisa Road, PO Box 291, Mbale, Uganda.
Eva NabawanukaDepartment of Paediatrics and Child Health, School of Medicine, Makerere University and Mulago Hospital, PO Box 7072, Kampala, Uganda.
Tonny SennyondoMbale Clinical Research Institute, Pallisa Road, PO Box 291, Mbale, Uganda.
Denis AmorutSoroti Regional Referral Hospital, PO Box 289, Soroti, Uganda.
C Williams MusikaDepartment of Paediatrics and Child Health, School of Medicine, Makerere University and Mulago Hospital, PO Box 7072, Kampala, Uganda.
Imelda BatesLiverpool School of Tropical Medicine and Hygiene, Liverpool, UK.
M Boele van HensbroekEmma Children's Hospital AMC Amsterdam, Amsterdam, The Netherlands.
Jennifer A EvansDepartment of Paediatrics, University Hospital of Wales, Heath Park Cardiff, Cardiff, CF14 4XW, Wales.
Sophie UyogaKEMRI-Wellcome Trust Research Programme, PO Box 230, Kilifi, Kenya.
Thomas N WilliamsKEMRI-Wellcome Trust Research Programme, PO Box 230, Kilifi, Kenya.
Gary FrostInstitute of Global Health and Innovation, Department of Medicine, Imperial College London, London, SW7 2AZ, UK.
Diana M Gibb *MRC Clinical Trials Unit at University College London, 90 High Holborn, London, WC1V 6LJ, UK.
Kathryn Maitland *KEMRI-Wellcome Trust Research Programme, PO Box 230, Kilifi, Kenya.
A Sarah Walker *MRC Clinical Trials Unit at University College London, 90 High Holborn, London, WC1V 6LJ, UK.
TRACT trial group
University Hospital of Wales · GBKenya Medical Research Institute · KEEmma Kinderziekenhuis · NLMRC Clinical Trials Unit at UCL · GBSoroti Hospital · UGImperial College London · GBMulago Hospital · UGLiverpool School of Tropical Medicine · GBMbale Hospital · UGQueen's University Belfast · GBUniversity of Liverpool · GBBusitema University · UG

Funding

Medical Research Council MC_UU_00004/05Medical Research Council MC_UU_12023/26Medical Research Council MR/J012483/1Wellcome Trust 202800/Z/16/Z
6 · The paper itself

Abstract

backgroundSevere anaemia (haemoglobin < 6 g/dL) is a leading cause of recurrent hospitalisation in African children. We investigated predictors of readmission in children hospitalised with severe anaemia in the TRACT trial (ISRCTN84086586) in order to identify potential future interventions.

methodsSecondary analyses of the trial examined 3894 children from Uganda and Malawi surviving a hospital episode of severe anaemia. Predictors of all-cause readmission within 180 days of discharge were identified using multivariable regression with death as a competing risk. Groups of children with similar characteristics were identified using hierarchical clustering.

resultsOf the 3894 survivors 682 (18%) were readmitted; 403 (10%) had ≥2 re-admissions over 180 days. Three main causes of readmission were identified: severe anaemia (n = 456), malaria (n = 252) and haemoglobinuria/dark urine syndrome (n = 165). Overall, factors increasing risk of readmission included HIV-infection (hazard ratio 2.48 (95% CI 1.63-3.78), p < 0.001); ≥2 hospital admissions in the preceding 12 months (1.44(1.19-1.74), p < 0.001); history of transfusion (1.48(1.13-1.93), p = 0.005); and missing ≥1 trial medication dose (proxy for care quality) (1.43 (1.21-1.69), p < 0.001). Children with uncomplicated severe anaemia (Hb 4-6 g/dL and no severity features), who never received a transfusion (per trial protocol) during the initial admission had a substantially lower risk of readmission (0.67(0.47-0.96), p = 0.04). Malaria (among children with no prior history of transfusion) (0.60(0.47-0.76), p < 0.001); younger-age (1.07 (1.03-1.10) per 1 year younger, p < 0.001) and known sickle cell disease (0.62(0.46-0.82), p = 0.001) also decreased risk of readmission. For anaemia re-admissions, gross splenomegaly and enlarged spleen increased risk by 1.73(1.23-2.44) and 1.46(1.18-1.82) respectively compared to no splenomegaly. Clustering identified four groups of children with readmission rates from 14 to 20%. The cluster with the highest readmission rate was characterised by very low haemoglobin (mean 3.6 g/dL). Sickle Cell Disease (SCD) predominated in two clusters associated with chronic repeated admissions or severe, acute presentations in largely undiagnosed SCD. The final cluster had high rates of malaria (78%), severity signs and very low platelet count, consistent with acute severe malaria.

conclusionsYounger age, HIV infection and history of previous hospital admissions predicted increased risk of readmission. However, no obvious clinical factors for intervention were identified. As missing medication doses was highly predictive, attention to care related factors may be important.

trial registrationISRCTN ISRCTN84086586 .

Indexed as

AnemiaHIV InfectionsChildHumansIncidenceMalawiPatient ReadmissionUgandaReadmissionSevere anaemia

Identifiers

PMID34325680
PMCPMC8323322
OpenAlexW3185364064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.